Method for deacetylation of biopolymers
A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH 2 OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially deacetylated biopolymer.
1 . A method of preparing a hydrogel product comprising crosslinked glycosaminoglycan molecules, the method comprising:
(a) deacetylating glycosaminoglycans using a hydroxylamine salt to produce at least partially deacetylated glycosaminoglycans, wherein the hydroxylamine salt is formed by hydroxylamine and an acid, wherein the acid is selected from:
mineral acids selected from the group consisting of: sulfuric acid, hydrochloric acid, hydroiodic acid, hydrobromic acid, phosphoric acid, and mixtures thereof; and
organic acids selected from the group consisting of: acetic acid, propionic acid, pivalic acid, citric acid, oxalic acid, malonic acid, lactic acid, benzoic acid, halogenated carboxylic acids, and mixtures thereof;
(b) crosslinking the at least partially deacetylated glycosaminoglycans using a crosslinker, wherein the crosslinking comprises forming amide bonds between activated carboxyl groups of the at least partially deacetylated glycosaminoglycans and nucleophiles on the crosslinker, wherein the crosslinked at least partially deacetylated glycosaminoglycans comprise residual amine groups;
(c) acylating the crosslinked at least partially deacetylated glycosaminoglycans.
2 . The method of claim 1 , wherein:
the crosslinked at least partially deacetylated glycosaminoglycans comprise ester crosslinks; and
the method further comprises (d) subjecting the acylated crosslinked glycosaminoglycans from (c) to alkaline treatment to hydrolyze the ester crosslinks.
3 . The method of claim 1 , wherein the activated carboxyl groups of the at least partially deacetylated glycosaminoglycans in (b) are obtained by: activating carboxyl groups on the at least partially deacetylated glycosaminoglycan with a coupling agent.
4 . The method of claim 1 , wherein the glycosaminoglycan is selected from the group consisting of hyaluronic acid, chondroitin, chondroitin sulfate, and mixtures thereof.
5 . The method of claim 1 , wherein the deacetylating in (a) is performed using a solution comprising:
the glycosaminoglycans; and
the hydroxylamine or salt thereof at a concentration of 0.01 M to 10 M.
6 . The method of claim 1 , wherein the deacetylating in (a) is performed at a temperature from 10° C. to 90° C., for a time from 5 minutes to 200 hours.
7 . The method of claim 1 , wherein the at least partially deacetylated glycosaminoglycans produced in (a) have a degree of acetylation of 99% or less.
8 . The method of claim 1 , wherein the deacetylating in (a) causes a reduction in molecular weight of the glycosaminoglycans of 90% or less.
9 . The method of claim 1 , wherein the crosslinker is a carbohydrate-based di-amine or multi-amine functional crosslinker selected from di-saccharides, tri-saccharides, tetra-saccharides, oligosaccharides, and polysaccharides.
10 . The method of claim 1 , wherein the crosslinker comprises diaminotrehalose (DATH).
11 . The method of claim 1 , wherein the crosslinker comprises a second at least partially deacetylated polysaccharide selected from the group consisting of: hyaluronic acid, chondroitin, chondroitin sulfate, and mixtures thereof.
12 . The method of claim 2 , wherein after the alkaline treatment in (d), at least 95% of the bonds between the glycosaminoglycans are amide bonds.
13 . A method of preparing a hydrogel product comprising crosslinked glycosaminoglycan molecules, the method comprising:
(a) deacetylating glycosaminoglycans using a hydroxylamine or salt thereof to produce at least partially deacetylated glycosaminoglycans;
(b) crosslinking the at least partially deacetylated glycosaminoglycans using a crosslinker comprising diaminotrehalose (DATH), wherein the crosslinking comprises forming amide bonds between activated carboxyl groups of the at least partially deacetylated glycosaminoglycans and nucleophiles on the DATH, wherein the crosslinked at least partially deacetylated glycosaminoglycans comprise residual amine groups;
(c) acylating the crosslinked at least partially deacetylated glycosaminoglycans.
14 . The method of claim 13 , wherein:
the crosslinked at least partially deacetylated glycosaminoglycans comprise ester crosslinks; and
the method further comprises (d) subjecting the acylated crosslinked glycosaminoglycans from (c) to alkaline treatment to hydrolyze the ester crosslinks.
15 . The method of claim 13 , wherein the glycosaminoglycan is selected from the group consisting of hyaluronic acid, chondroitin, chondroitin sulfate, and mixtures thereof.
16 . The method of claim 13 , wherein the deacetylating in (a) is performed using a hydroxylamine salt formed by hydroxylamine and an acid, wherein the acid is selected from:
mineral acids selected from the group consisting of: sulfuric acid; hydrochloric acid; hydroiodic acid; hydrobromic acid; phosphoric acid; and mixtures thereof; and
organic acids selected from the group consisting of: acetic acid; propionic acid; pivalic acid; citric acid; oxalic acid; malonic acid; lactic acid; benzoic acid; halogenated carboxylic acids; and mixtures thereof.
17 . The method of claim 13 , wherein the deacetylating in (a) is performed using a solution comprising:
the glycosaminoglycans; and
the hydroxylamine or salt thereof at a concentration of 0.01 M to 10 M.
18 . The method of claim 13 , wherein the deacetylating in (a) is performed at a temperature from 10° C. to 90° C., for a time from 5 minutes to 200 hours.
19 . The method of claim 13 , wherein the at least partially deacetylated glycosaminoglycans produced in (a) have a degree of acetylation of 99% or less.
20 . The method of claim 13 , wherein the crosslinker comprises a second at least partially deacetylated polysaccharide selected from the group consisting of: hyaluronic acid, chondroitin, chondroitin sulfate, and mixtures thereof.
21 . The method of claim 14 , wherein after the alkaline treatment in (d), at least 95% of the bonds between the glycosaminoglycans are amide bonds.